Welcome to LookChem.com Sign In|Join Free

CAS

  • or

188527-03-9

Post Buying Request

188527-03-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

188527-03-9 Usage

Description

Tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate is a chemical compound with a molecular formula C17H24BrNO2S. It is an ester derivative of piperidine, containing a tert-butyl group and a 4-(4-bromophenylthio) substituent. tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate has potential applications in the field of organic chemistry, pharmaceuticals, and agrochemicals.

Uses

Used in Organic Chemistry:
Tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure allows for versatile chemical reactions, making it a valuable building block in organic synthesis.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate is used as a precursor in the synthesis of bioactive molecules and drug candidates. Its presence in the molecule can impart specific pharmacological properties, contributing to the development of new therapeutic agents.
Used in Agrochemicals:
Tert-butyl 4-(4-bromophenylthio)piperidine-1-carboxylate is also utilized in the agrochemical sector as an intermediate for the synthesis of agrochemical products. Its chemical properties can be harnessed to create compounds with pesticidal or herbicidal activities, contributing to crop protection and yield enhancement.

Check Digit Verification of cas no

The CAS Registry Mumber 188527-03-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,5,2 and 7 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 188527-03:
(8*1)+(7*8)+(6*8)+(5*5)+(4*2)+(3*7)+(2*0)+(1*3)=169
169 % 10 = 9
So 188527-03-9 is a valid CAS Registry Number.

188527-03-9Relevant articles and documents

Synthesis and Characterization of N-(4-(Piperidin-4-ylsulfonyl) phenyl)5-vinylpyrimidin-2-amine

Dong, Jingjing,Feng, Baicheng,Jin, Yan,Lu, Jianqiang,Wang, Tielin

, p. 255 - 258 (2021/08/05)

Target product N-(4-(piperidin-4-ylsulfonyl)phenyl)5-vinylpyrimidin-2- amine (13) was synthesized using 6-oxopyran-3-carbaldehyde (M1) and 4-hydroxypiperidine (M2) as starting materials by a series of nucleophilic substitution and oxidation. Different aci

Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)

Dragovich, Peter S.,Bair, Kenneth W.,Baumeister, Timm,Ho, Yen-Ching,Liederer, Bianca M.,Liu, Xiongcai,Liu, Yongbo,O'Brien, Thomas,Oeh, Jason,Sampath, Deepak,Skelton, Nicholas,Wang, Leslie,Wang, Weiru,Wu, Hongxing,Xiao, Yang,Yuen, Po-Wai,Zak, Mark,Zhang, Lei,Zheng, Xiaozhang

, p. 4875 - 4885 (2013/09/02)

Potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors containing 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas were identified using structure-based design techniques. The new compounds displayed improved aqueous solubilities, determined using a high-throughput solubility assessment, relative to previously disclosed urea and amide-containing NAMPT inhibitors. An optimized 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived compound exhibited potent anti-NAMPT activity (18; BC NAMPT IC50 = 11 nM; PC-3 antiproliferative IC50 = 36 nM), satisfactory mouse PK properties, and was efficacious in a PC-3 mouse xenograft model. The crystal structure of another optimized compound (29; NAMPT IC50 = 10 nM; A2780 antiproliferative IC50 = 7 nM) in complex with the NAMPT protein was also determined.

THIAZOLE INHIBITORS TARGETING RESISTANT AND KINASE MUTATIONS

-

Page/Page column 51-52, (2010/11/27)

A compound is provided, having the general structure (A): wherein A is an aryl or heteroaryl group, Y is a hydrophobic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 188527-03-9